Publications by authors named "Dannel Yeo"

6Publications

Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer.

Int J Cancer 2017 05 7;140(9):2101-2111. Epub 2017 Feb 7.

Department of Surgery, University of Melbourne. Austin Health, Melbourne, VIC, Australia.

View Article and Find Full Text PDF
May 2017

Glaucarubinone Combined with Gemcitabine Improves Pancreatic Cancer Survival in an Immunocompetent Orthotopic Murine Model.

J Invest Surg 2016 Dec 30;29(6):366-372. Epub 2016 Mar 30.

a Department of Surgery , University of Melbourne, Austin Health , Melbourne , Victoria , Australia.

View Article and Find Full Text PDF
December 2016

FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine.

BMC Cancer 2016 Jan 16;16:24. Epub 2016 Jan 16.

Department of Surgery, Austin Health, University of Melbourne, Heidelberg, VIC, Australia.

View Article and Find Full Text PDF
January 2016

The role of p21-activated kinases in pancreatic cancer.

Pancreas 2015 Apr;44(3):363-9

From the Department of Surgery, University of Melbourne, Austin Health, Heidelberg, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
April 2015

Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases.

Cancer Lett 2014 May 31;346(2):264-72. Epub 2014 Jan 31.

Department of Surgery, University of Melbourne, Austin Health, Melbourne, Victoria 3084, Australia. Electronic address:

View Article and Find Full Text PDF
May 2014

Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma.

J Invest Surg 2013 Dec 19;26(6):352-9. Epub 2013 Aug 19.

1 Department of Surgery, Austin Health, University of Melbourne, Austin Health, LTB8, Heidleberg, Victoria, Australia.

View Article and Find Full Text PDF
December 2013